THE BEHAVIORAL TOXICITY OF THE SELECTIVE SEROTONIN REUPTAKE INHIBITORS

被引:48
|
作者
HINDMARCH, I
机构
[1] University of Surrey, Milford Hospital Godalming, Surrey
关键词
BEHAVIORAL TOXICITY; CHOICE REACTION TIME; CRITICAL FLICKER FUSION THRESHOLD; MAJOR DEPRESSION; SEROTONIN REUPTAKE INHIBITORS; TRICYCLIC ANTIDEPRESSANTS;
D O I
10.1097/00004850-199501004-00002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The serotonin reuptake inhibitors (SSRIs) are generally better tolerated than the traditional tricyclic antidepressants (TCAs) in the treatment of major depression. In particular the SSRIs are relatively free from cognitive and psychomotor effects Likely to cause behavioural toxicity. Behavioural toxicity is studied using a battery of psychometric assessments. This paper discusses the effects of the TCAs and SSRIs on two such assessments, choice reaction time (CRT) and critical flicker fusion threshold (CFFT). CRT measures psychomotor speed, and CFFT assesses the information processing capacity of the CNS. The behavioural toxicity associated with the traditional TCAs can lead to an increased accident risk, whereas the SSRIs are not associated with such effects. Clinically relevant differences in the behavioural toxicity of the SSRIs are highlighted.
引用
收藏
页码:13 / 17
页数:5
相关论文
共 50 条
  • [21] Early Life Adversity as a Moderator of Symptom Change following Selective Serotonin Reuptake Inhibitors and Cognitive Behavioral Therapy
    Gruhn, Meredith A.
    Luan Phan, K.
    Klumpp, Heide
    Ajilore, Olusola
    Gorka, Stephanie M.
    COGNITIVE THERAPY AND RESEARCH, 2021, 45 (02) : 343 - 354
  • [22] Effects of selective serotonin reuptake inhibitors on platelet serotonin parameters in major depressive disorder
    Bakish, D
    Cavazzoni, P
    Chudzik, J
    Ravindran, A
    Hrdina, PD
    BIOLOGICAL PSYCHIATRY, 1997, 41 (02) : 184 - 190
  • [23] Brain serotonin transporter availability predicts treatment response to selective serotonin reuptake inhibitors
    Kugaya, A
    Sanacora, G
    Staley, JK
    Malison, RT
    Bozkurt, A
    Khan, S
    Anand, A
    van Dyck, CH
    Baldwin, RM
    Seibyl, JP
    Charney, D
    Innis, RB
    BIOLOGICAL PSYCHIATRY, 2004, 56 (07) : 497 - 502
  • [24] Comparative Efficacy and Safety of Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors in Older Adults: A Network Meta-Analysis
    Thorlund, Kristian
    Druyts, Eric
    Wu, Ping
    Balijepalli, Chakrapani
    Keohane, Denis
    Mills, Edward
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2015, 63 (05) : 1002 - 1009
  • [25] Selective serotonin reuptake inhibitors and manic switch: A pharmacovigilance and pharmacodynamical study
    Ciray, R. Ogulcan
    Halac, Eren
    Turan, Serkan
    Tuncturk, Mustafa
    Ozbek, Mutlu
    Ermis, Cagatay
    ASIAN JOURNAL OF PSYCHIATRY, 2021, 66
  • [26] Length of therapy with selective serotonin reuptake inhibitors and tricyclic antidepressants in Australia
    McManus, P
    Mant, A
    Mitchell, P
    Dudley, J
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2004, 38 (06) : 450 - 454
  • [27] Interaction of Selective Serotonin Reuptake Inhibitors with Neuronal Nicotinic Acetylcholine Receptors
    Arias, Hugo R.
    Feuerbach, Dominik
    Targowska-Duda, Katarzyna M.
    Russell, Megan
    Jozwiak, Krzysztof
    BIOCHEMISTRY, 2010, 49 (27) : 5734 - 5742
  • [28] Selective serotonin reuptake inhibitors in human pregnancy: On the way to resolving the controversy
    Ornoy, Asher
    Koren, Gideon
    SEMINARS IN FETAL & NEONATAL MEDICINE, 2014, 19 (03) : 188 - 194
  • [29] Pharmacogenetics of Selective Serotonin Reuptake Inhibitors and Associated Adverse Drug Reactions
    Thomas, Kelan L. H.
    Ellingrod, Vicki L.
    PHARMACOTHERAPY, 2009, 29 (07): : 822 - 831
  • [30] Risk of Fractures with Selective Serotonin-Reuptake Inhibitors or Tricyclic Antidepressants
    Ginzburg, Regina
    Rosero, Enma
    ANNALS OF PHARMACOTHERAPY, 2009, 43 (01) : 98 - 103